文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

表征具有流感血凝素的植物来源病毒样颗粒的先天刺激能力。

Characterization of the innate stimulatory capacity of plant-derived virus-like particles bearing influenza hemagglutinin.

机构信息

Departments of Physiology and Microbiology & Immunology, Goodman Cancer Research Center, 3655 Promenade Sir William Osler, Montréal, Québec H3G 1Y6, Canada.

Medicago Inc., 1020 route de l'Église, suite 600, Québec, Québec G1V 3V9, Canada.

出版信息

Vaccine. 2018 Dec 18;36(52):8028-8038. doi: 10.1016/j.vaccine.2018.10.099. Epub 2018 Nov 14.


DOI:10.1016/j.vaccine.2018.10.099
PMID:30448064
Abstract

Cell-mediated immunity is an important component of immediate and long-term anti-viral protection. Dendritic cells (DCs) are essential for the induction of cell-mediated immunity by instructing the activation and differentiation of antigen-specific T cell responses. Activated DCs that express co-stimulatory molecules and pro-inflammatory cytokines are necessary to promote the development of type 1 immune responses required for viral control. Here we report that plant-derived virus-like particles (VLPs) bearing influenza hemagglutinins (HA) directly stimulate mouse and human DCs. DCs exposed to H1- and, to a lesser extent, H5-VLPs in vitro rapidly express co-stimulatory molecules and produce pro-inflammatory cytokines including IL-12, IL-6 and TNFα. Furthermore, these VLPs support the activation and differentiation of antigen-specific T cell responses. Mechanistically, H1-VLPs stimulate the activation of kinases typically activated downstream of pattern recognition receptors including AKT, p38, and p42/44 ERK. In vivo, immunization with plant-derived VLPs induce the accumulation of both cDC1s and cDC2 in the draining lymph node and a corresponding increase in T and B cells. VLPs devoid of HA protein activate DCs, suggesting they are intrinsically immunostimulatory. Together, the results demonstrate that these candidate plant-derived VLP vaccines have an inherent and direct stimulatory effect on DCs and can enhance the ability of DCs to promote Type 1 immune responses.

摘要

细胞介导的免疫是即时和长期抗病毒保护的重要组成部分。树突状细胞 (DCs) 通过指导抗原特异性 T 细胞反应的激活和分化,对于诱导细胞介导的免疫至关重要。表达共刺激分子和促炎细胞因子的激活 DC 对于促进控制病毒所需的 1 型免疫反应的发展是必要的。在这里,我们报告了携带流感血凝素 (HA) 的植物来源病毒样颗粒 (VLPs) 可直接刺激小鼠和人类 DCs。体外暴露于 H1-和(在较小程度上)H5-VLPs 的 DCs 迅速表达共刺激分子并产生促炎细胞因子,包括 IL-12、IL-6 和 TNFα。此外,这些 VLPs 支持抗原特异性 T 细胞反应的激活和分化。从机制上讲,H1-VLPs 刺激通常在模式识别受体下游激活的激酶的激活,包括 AKT、p38 和 p42/44 ERK。在体内,用植物来源的 VLPs 免疫会导致引流淋巴结中 cDC1 和 cDC2 的积累,以及 T 和 B 细胞的相应增加。缺乏 HA 蛋白的 VLPs 激活 DCs,表明它们具有内在的免疫刺激性。总之,这些结果表明这些候选植物源性 VLP 疫苗对 DCs 具有固有和直接的刺激作用,并增强了 DCs 促进 1 型免疫反应的能力。

相似文献

[1]
Characterization of the innate stimulatory capacity of plant-derived virus-like particles bearing influenza hemagglutinin.

Vaccine. 2018-11-14

[2]
Morphological characterization of a plant-made virus-like particle vaccine bearing influenza virus hemagglutinins by electron microscopy.

Vaccine. 2018-3-14

[3]
Plant-made virus-like particle vaccines bearing the hemagglutinin of either seasonal (H1) or avian (H5) influenza have distinct patterns of interaction with human immune cells in vitro.

Vaccine. 2017-5-2

[4]
Enhanced Influenza Virus-Like Particle Vaccination with a Structurally Optimized RIG-I Agonist as Adjuvant.

J Virol. 2015-10

[5]
Structural basis for the development of avian virus capsids that display influenza virus proteins and induce protective immunity.

J Virol. 2015-3

[6]
A Bivalent Heterologous DNA Virus-Like-Particle Prime-Boost Vaccine Elicits Broad Protection against both Group 1 and 2 Influenza A Viruses.

J Virol. 2017-4-13

[7]
Plant-made virus-like particles bearing influenza hemagglutinin (HA) recapitulate early interactions of native influenza virions with human monocytes/macrophages.

Vaccine. 2017-8-16

[8]
Vaccine molecules targeting Xcr1 on cross-presenting DCs induce protective CD8+ T-cell responses against influenza virus.

Eur J Immunol. 2015-2

[9]
A Single Intramuscular Dose of a Plant-Made Virus-Like Particle Vaccine Elicits a Balanced Humoral and Cellular Response and Protects Young and Aged Mice from Influenza H1N1 Virus Challenge despite a Modest/Absent Humoral Response.

Clin Vaccine Immunol. 2017-12-5

[10]
Hemagglutinin and neuraminidase containing virus-like particles produced in HEK-293 suspension culture: An effective influenza vaccine candidate.

Vaccine. 2016-6-17

引用本文的文献

[1]
Translatability scoring in prospective and retrospective COVID drug development cases.

Eur J Clin Pharmacol. 2023-8

[2]
Dose immunogenicity study of a plant-produced influenza virus-like particle vaccine in layer hens.

Heliyon. 2022-6-25

[3]
Unique features of a recombinant haemagglutinin influenza vaccine that influence vaccine performance.

NPJ Vaccines. 2021-12-2

[4]
Combating Human Viral Diseases: Will Plant-Based Vaccines Be the Answer?

Vaccines (Basel). 2021-7-8

[5]
Contributions of the international plant science community to the fight against human infectious diseases - part 1: epidemic and pandemic diseases.

Plant Biotechnol J. 2021-10

[6]
What Does Plant-Based Vaccine Technology Offer to the Fight against COVID-19?

Vaccines (Basel). 2020-4-14

[7]
Plant-derived virus-like particle vaccines drive cross-presentation of influenza A hemagglutinin peptides by human monocyte-derived macrophages.

NPJ Vaccines. 2019-5-15

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索